Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial
Principal Investigator
Study Number
A151216
Summary
This study involves people with lung cancer, who have had, or will have, surgery to remove their lung cancer tumor(s). The purpose of this study is to examine lung cancer patients surgically removed tumors for certain genetic changes, and then to possibly refer these patients to a treatment study involving drugs that may specifically target tumors that have the same genetic changes. This study does not involve treatment, but is used to help identify people who may be eligible for other studies.
Phase
N/A
Contact
Available at the following location(s)
- Lebanon
View more details at ClinicalTrials.gov
Do you need help with some of the labels on this page?
Read our glossary of terms